We are live on
!
Find out more
Royce & Associates Portfolio holdings
AUM
$12.4B
Turnover
20.64%
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter
Est. Return
+2.79%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.6B
AUM Growth
-$258M
(-0.76%)
Cap. Flow
-$892M
Cap. Flow
% of AUM
-2.66%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
1,511
New
98
Increased
472
Reduced
496
Closed
89
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nu Skin
NUS
|
+$123M |
| 2 |
Dana Inc
DAN
|
+$61.6M |
| 3 |
BRCD
Brocade Communications Systems, Inc. NEW
BRCD
|
+$55.3M |
| 4 |
Civeo
CVEO
|
+$37.3M |
| 5 |
ePlus
PLUS
|
+$30M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zebra Technologies
ZBRA
|
+$107M |
| 2 |
Helmerich & Payne
HP
|
+$90.6M |
| 3 |
Oil States International
OIS
|
+$59.7M |
| 4 |
Reliance Steel & Aluminium
RS
|
+$59.4M |
| 5 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 24.45% |
| 2 | Technology | 18.1% |
| 3 | Consumer Discretionary | 14.79% |
| 4 | Financials | 9.92% |
| 5 | Materials | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NSR
1126
DELISTED
Neustar Inc
NSR
| $1.17M | ﹤0.01% |
44,987
-15,800
| -26% | -$429K |
2013 Q2
4 quarters
|
|
1127
Monarch Casino & Resort
MCRI
$2.08B
| $1.17M | ﹤0.01% |
77,000
| – | – |
2013 Q4
2 quarters
|
|
|
OHAI
1128
DELISTED
OHA Investment Corporation
OHAI
| $1.15M | ﹤0.01% |
185,034
+2,698
| +1% | +$17.5K |
2013 Q2
4 quarters
|
|
1129
Marchex
MCHX
$55M
| $1.14M | ﹤0.01% |
95,000
| – | – |
2013 Q2
4 quarters
|
|
1130
Belden
BDC
$3.99B
| $1.14M | ﹤0.01% |
14,603
-4,100
| -22% | -$301K |
2013 Q2
4 quarters
|
|
|
SNBC
1131
DELISTED
Sun Bancorp Inc
SNBC
| $1.14M | ﹤0.01% |
56,886
| – | – |
2013 Q2
4 quarters
|
|
1132
Avnet
AVT
$7.47B
| $1.13M | ﹤0.01% |
25,500
| – | – |
2013 Q2
4 quarters
|
|
1133
Deswell Industries
DSWL
$48.4M
| $1.12M | ﹤0.01% |
544,371
| – | – |
2013 Q2
4 quarters
|
|
1134
DELISTED
Monroe Capital Corp
MRCC
| $1.09M | ﹤0.01% |
82,431
| – | – |
2013 Q4
2 quarters
|
|
1135
Alaunos Therapeutics
TCRT
$5.26M
| $1.08M | ﹤0.01% |
1,787
-420
| -19% | -$234K |
2013 Q2
4 quarters
|
|
1136
Tronox
TROX
$562M
| $1.07M | ﹤0.01% |
39,800
| – | – |
2013 Q2
4 quarters
|
|
1137
Innovative Solutions & Support
IA
$331M
| $1.06M | ﹤0.01% |
142,828
| – | – |
2013 Q2
4 quarters
|
|
1138
BBVA Argentina
BBAR
$2.59B
| $1.06M | ﹤0.01% |
91,000
-75,700
| -45% | -$739K |
2014 Q1
1 quarter
|
|
1139
DELISTED
Leggett & Platt
LEG
| $1.06M | ﹤0.01% |
30,803
-8,200
| -21% | -$273K |
2013 Q2
4 quarters
|
|
|
RVBD
1140
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
| $1.03M | ﹤0.01% |
50,000
-4,000
| -7% | -$79.1K |
2014 Q1
1 quarter
|
|
|
CIT
1141
DELISTED
CIT Group Inc.
CIT
| $1.03M | ﹤0.01% |
22,500
+4,300
| +24% | +$194K |
2013 Q4
2 quarters
|
|
|
ARG
1142
DELISTED
Airgas Inc
ARG
| $1.02M | ﹤0.01% |
9,360
| – | – |
2013 Q2
4 quarters
|
|
|
SPA
1143
DELISTED
Sparton
SPA
| $1.02M | ﹤0.01% |
36,700
| – | – |
2013 Q2
4 quarters
|
|
1144
Alico
ALCO
$283M
| $1.01M | ﹤0.01% |
27,000
| – | – |
2013 Q2
4 quarters
|
|
1145
Piper Sandler
PIPR
$4.58B
| $994K | ﹤0.01% |
76,800
-1,320,348
| -95% | -$14.9M |
2013 Q2
4 quarters
|
|
1146
DELISTED
Novadaq Technologies Inc.
NVDQ
| $989K | ﹤0.01% |
60,000
-60,000
| -50% | -$988K |
2013 Q2
4 quarters
|
|
1147
Comstock Holding Companies
CHCI
$178M
| $971K | ﹤0.01% |
116,579
-17,171
| -13% | -$162K |
2013 Q2
4 quarters
|
|
1148
Cimpress
CMPR
$1.85B
| $971K | ﹤0.01% |
24,000
| – | – |
2013 Q2
4 quarters
|
|
1149
PNC Financial Services
PNC
$86.4B
| $971K | ﹤0.01% |
+10,900
| New | +$931K |
2014 Q2
0 quarters
|
|
|
DFBG
1150
DELISTED
Differential Brands Group Inc
DFBG
| $968K | ﹤0.01% |
30,432
-11,167
| -27% | -$350K |
2013 Q2
4 quarters
|
|
Similar funds
Royce & Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Royce & Associates held 1,511 positions worth $33.6B, down 0.76% from $33.9B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Royce & Associates's Q2 2014 filing shows 98 new, 472 increased, 496 reduced and 89 closed positions. Its largest new stake was Civeo: 124,691 shares worth $37.5M. The largest sale was Zebra Technologies, an estimated $107M.
By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
- Royce & Associates's largest Q2 2014 buy was Civeo: 124,691 shares worth $37.5M.
- Royce & Associates added most to Nu Skin in Q2 2014, an estimated $123M increase.
- Royce & Associates's biggest Q2 2014 reduction was Zebra Technologies, cutting an estimated $107M.
- Royce & Associates fully exited Entegris in Q2 2014, selling an estimated $35.5M.
- Royce & Associates's ten largest holdings make up 9.6% of its $33.6B portfolio in Q2 2014.
- Royce & Associates opened 98 new positions and closed 89 in Q2 2014.
- Royce & Associates's portfolio value fell 0.76% quarter-over-quarter to $33.6B.
Based on Royce & Associates's 13F filing for Q2 2014, filed 11 Aug 2014.